In a joint study with the University of California, San Francisco, Cardiogram was able to detect atrial fibrillation with 97% accuracy and both sleep apnea and hypertension at greater than an 82% accuracy. Cardiogram is also used day-to-day by patients with a variety of other cardiovascular and autonomic conditions such as supraventricular tachycardia, heart failure, and dysautonomia. Heart rhythm and autonomic irregularity are increasingly common diagnoses in some individuals who have recovered from COVID-19.
Harish Kilaru, Senior Vice President at ilumivu, explains: "Patients with cardiovascular disease often lack tools to monitor their heart health outside the doctor's office. Cardiogram empowers users to better understand their heart health patterns and to share the data with their doctors and caregivers. With many COVID-19 patients becoming long-haulers and experiencing cardiovascular symptoms and over 30 million adults diagnosed with heart disease, remote monitoring of heart conditions is increasingly necessary."
Supporting the acquisition of Cardiogram is a follow-on investment by Health Catalyst Capital, the largest shareholder of Cardiogram. Charles Boorady, Founder and Managing Partner of Health Catalyst Capital, stated "Our investment in ilumivu demonstrates our confidence in the ability of its management team, working with Harish Kilaru and others from Cardiogram, to utilize both its own software and Cardiogram's cardio app technology to build a preeminent digital healthcare business that will improve patient outcomes and reduce healthcare costs".
About ilumivu
Founded in 2009, ilumivu provides healthcare decision support applications using the psychology of behavior change, combined with real-time data from smartphones and wearables. With a pedigree in research in multiple disease areas at over 70 leading research universities and health systems, ilumivu delivers just-in-time adaptive interventions based on individualized baselines to improve measurable patient care outcomes.
About Cardiogram
Founded in 2016, Cardiogram developed a leading cardiovascular health decision support application that helps users manage chronic health conditions and detect undiagnosed conditions. The Cardiogram neural network – DeepHeart - uses artificial intelligence to make life-saving inferences from heart and other biometric data generated by smartwatches. Cardiogram supports smartwatches from Apple Watch, Garmin, Samsung, WearOS by Google, and Fitbit.
